CDC Wants MMR and MMRV Vaccine Comments By December 19, 2016
Time is running out to submit your comments to the CDC regarding the problematic MMR and MMRV vaccines given to infants and toddlers, which many think have an adverse impact on Autism.
I filed a 10-page comment, which is below, on December 14th. Guess how many comments were posted as of that date? A measly 236! The last time the CDC asked for comments, consumers posted over 15,000!
Earlier, I wrote an article about the CDC’s request for comments, which I heartily suggest you read and file your complaint. You can get some ideas from what I said in my filing, so please file your comment before midnight of Tuesday, December 19, 2016. Please don’t let an important opportunity slip by regarding vaccines that harm infants, toddlers and children.
Here’s the CDC website where you can file your complaint https://www.regulations.gov/docket?D=CDC-2016-0094, and thank you!
Proposed Revised Vaccine Information Materials for MMR (Measles, Mumps, and Rubella) and MMRV (Measles, Mumps, Rubella, and Varicella) Vaccines
>>Docket ID: CDC-2016-0094<<
Agency: Centers for Disease Control and Prevention (CDC)
Due Date: Dec. 19, 2016
Please accept the following information regarding MMR and MMRV vaccines, based upon published scientific research and studies, which I enumerate first, and follow with my comments that CDC requests regarding REVISED Vaccine Information Materials for MMR and MMRV Vaccines.
My comments are based upon studying published vaccine research since the 1980s and using the synopsis of 400 scientific papers in the 2016 book “Critical Vaccine Studies” by Neil Z. Miller.
Published Peer Review Studies
Med Sci Monit 2004 Mar; 10(3): P133-9.
A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Geier DA, Geier MR.
“There is biological plausibility and epidemiological evidence showing a direct relationship between increasing doses of mercury from thimerosal-containing vaccines and neurodevelopmental disorders, and measles-containing vaccines and serious neurological disorders. It is recommended that thimerosal be removed from all vaccines, and additional research be undertaken to produce an MMR vaccine with an improved safety profile.”
Clin Infect Dis 2014 May; 58(9): 1205-10.
Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.
Rosen JB, Rota JS, et al.
“This is the first report in which a person with a verified secondary vaccine failure despite receipt of two doses of MMR was demonstrated to be capable of transmitting disease to other individuals.”
J Infect Dis 2013 Mar 15; 207(6): 990-98.
Largest measles epidemic in North America in a decade—Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events.
DeSerres G, Markowski F, et al.
“This outbreak raises important questions concerning the relative contributions of vaccine failure versus failure to vaccinate.”
J Biomed Sci 2002 Jul-Aug; 9(4): 359-64.
Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.
Singh VK, Lin SX, et al.
“Over 90% of MMR antibody-positive autistic sera were also positive for MBP autoantibodies, suggesting a strong association between MMR and central nervous system autoimmunity in autism. Stemming from this evidence, we suggest that an inappropriate antibody response to MMR, specifically the measles component thereof, might be related to pathogenesis of autism.”
J Public Health Epidemiol 2014 Sep; 6(9): 271-86.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1470694951173-5'); });
//tags-cdn.deployads.com/a/activistpost.com.js
(deployads = window.deployads || ).push({});